REQUEST A DEMO
Total
USD $0.00
Search more companies

Sale Pharma Colombia S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sale Pharma Colombia S A S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sale Pharma Colombia S A S is a company in Colombia, with a head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on August 23, 2009. There are currently 1 (2024) people employed by Sale Pharma Colombia S A S. From the latest financial highlights, Sale Pharma Colombia S A S reported a net sales revenue increase of 49.73% in 2023. During that time, Sale Pharma Colombia S A S’s total assets grew by 5.56%. In 2023, Sale Pharma Colombia S A S’s net profit margin decreased by 0.78%.

Headquarters
Cl 74 # 86 40 T: 2 Ap 915
Bogota D.C.; Bogota D.C; Postal Code: 0919

Contact Details: Purchase the Sale Pharma Colombia S A S report to view the information.

Basic Information
Total Employees:
Purchase the Sale Pharma Colombia S A S report to view the information.
Outstanding Shares:
Purchase the Sale Pharma Colombia S A S report to view the information.
Incorporation Date:
August 23, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sale Pharma Colombia S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
49.73%
Total operating revenue
49.73%
Operating profit (EBIT)
25.43%
Net Profit (Loss) for the Period
25.43%
Total assets
5.56%
Total equity
5.42%
Operating Profit Margin (ROS)
-1.42%
Net Profit Margin
-0.78%
Return on Equity (ROE)
0.76%
Quick Ratio
-0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?